MOH Research Note — Medical Costs Stay Unresolved
Molina's raised outlook faces a 92.2% medical-cost ratio, a 57% ACA membership decline and weak price structure.
Market Outlooks
MOH Deep Coverage Review — Analysis as of August 3, 2026
Molina's earnings beat faces a 92.2% medical-cost ratio, a 57% ACA membership decline and unresolved valuation evidence.
Closing Market Recap — Monday, August 3, 2026
Closing Market Recap for Monday, August 3, 2026. How the day closed: indexes, leaders, laggards, and volatility.
Desk Note — PLTR Clears the Earnings Bar · Aug 03
Palantir’s commercial growth and raised outlook clear the bull-case tests in the July 30 review, while valuation remains the next question.
ASML Research Note — Cycle Still Needs Bookings Proof
ASML’s Q2 revenue rose 11% and new-system shipments rose 28%, but missing net bookings and weak price structure leave the cycle unconfirmed.
ASML Deep Coverage Review — Analysis as of August 3, 2026
ASML’s Q2 revenue rose 11% and new-system shipments rose 28%, but missing bookings confirmation and weak price structure keep the cycle unresolved.
MS Research Note — Results Lead the Tape
Morgan Stanley’s record quarter strengthens the operating case, while sector lag and an unresolved Wealth Management question raise the proof bar.
MS Deep Coverage Review — Analysis as of August 3, 2026
Morgan Stanley’s record returns strengthen the franchise case, but relative weakness and an unresolved control question keep the valuation contested.
Desk Note — Manufacturing Reaccelerates, Rates Reprice · Aug 03
July manufacturing activity accelerated sharply, strengthening cyclical rotation evidence while keeping rate sensitivity in focus.
Midday Market Check — Monday, August 3, 2026
Midday Market Check for Monday, August 3, 2026. Where the session stands: breadth, sectors, and what moved.